Noctura 6C tablets
Authorisation HOA1149/003/001 · A. Nelson & Company Limited
- Licence holder
- A. Nelson & Company Limited (all products →)
- Active substances
- Valeriana officinalis, Potassium bromide, Passiflora incarnata, Coffea arabica
- Clinical trials
- 3 clinical trials →
- Dosage form
- Tablet
- Route of administration
- Oral use
- First authorised
- 15/05/2020
- Prescription status
- Product not subject to medical prescription
- Supply
- Supply through non-pharmacy outlets and pharmacies
- Legal basis
- National Rules Authorisation (Article 16.2 Directive 2001/83/EC.)
Valeriana officinalis: supply and approvals
1 authorised product on the HPRA list contains Valeriana officinalis. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 6 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 5 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 6 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Potassium bromide: supply and approvals
67 authorised products on the HPRA list contain Potassium bromide. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 6 Nov 2026)
- US shortage (FDA)
- Potassium Chloride Tablet, Extended Release: resolved, updated 21 Nov 2025
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 6 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Passiflora incarnata: supply and approvals
1 authorised product on the HPRA list contains Passiflora incarnata. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 6 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 5 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 6 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 6 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.